In summary, while clinical studies link AQP4 to prognosis, edema severity, and genetic susceptibility, experimental models provide a deeper understanding of its biphasic role, regional variability, and therapeutic potential, highlighting both protective and pathological effects in ischemic stroke. The gene discussed is AQP4; the disease is ischemic stroke.